---
title: "Madrigal Pharma (MDGL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDGL.US/norm.md"
symbol: "MDGL.US"
name: "Madrigal Pharma"
parent: "https://longbridge.com/en/quote/MDGL.US.md"
datetime: "2026-05-20T06:05:56.975Z"
locales:
  - [en](https://longbridge.com/en/quote/MDGL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDGL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDGL.US/norm.md)
---

# Madrigal Pharma (MDGL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -3.25 | -2.57 | -5.08 | -1.90 | -2.61 |
| ROE | -65.88% | -38.15% | -69.12% | -24.05% | -39.99% |
| Revenue | 311.34M | 321.08M | 287.27M | 212.80M | 137.25M |
| Net income | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M |
| Operating income | -92.72M | -59.61M | -113.97M | -47.20M | -79.31M |
| Gross margin | 91.38% | 92.39% | 93.69% | 95.74% | 96.71% |
| Net margin | -30.32% | -18.24% | -39.75% | -19.87% | -53.36% |
| Profit quality | - | - | -142.74% | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.23B | 1.26B | 1.36B | 1.02B | 996.63M |
| Leverage | 2.26 | 2.09 | 2.18 | 1.46 | 1.40 |
| BVPS | 23.59 | 26.39 | 27.56 | 31.32 | 32.03 |
| Turnover | 1.02 | 0.8327 | 0.6081 | 0.4875 | 0.3053 |
| Cash & STI | 812.77M | 983.56M | 1.11B | 797.02M | 843.07M |
| Inv & Rec | 112.07M | 74.84M | 69.32M | 63.50M | 55.24M |
| LT assets | 14.24M | 6.44M | 8.30M | 7.48M | 4.01M |
| Net debt | -465.46M | -635.93M | -763.35M | -673.08M | -723.30M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -167.44M | -133.46M | 79.85M | -47.05M | -88.89M |
| Investing CF | 192.19M | 27.58M | -207.00M | 47.86M | 163.88M |
| Financing CF | 2.33M | 8.96M | 236.65M | 1.74M | 8.64M |
| Free CF | -107.02M | -115.47M | 117.34M | -36.10M | -68.51M |
| OCF coverage | -4350.09% | 34220.51% | 65.17% | - | - |
| Repaid & issued | - | 0.0000 | 350.00M | - | - |
| CapEx | -3.85M | 390000.00 | -857000.00 | - | - |